Acadia Pharmaceuticals Inc

J.W. COLE ADVISORS, INC. ACAD

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

20,632

Value ($000)

551

Weight

0.0%

2019 Q4 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	551	0.0%	20,632	12/31/2025
2025 Q3	11/5/2025	430	0.0%	20,131	9/30/2025
2025 Q2	8/12/2025	431	0.0%	19,981	6/30/2025
2025 Q1	5/5/2025	382	0.0%	23,026	3/31/2025
2024 Q4	1/31/2025	323	0.0%	17,620	12/31/2024
2024 Q3	10/24/2024	271	0.0%	17,620	9/30/2024
2024 Q2	8/8/2024	286	0.0%	17,620	6/30/2024
2024 Q1	4/30/2024	326	0.0%	17,620	3/31/2024
2023 Q4	1/31/2024	552	0.0%	17,620	12/31/2023
2023 Q3	10/24/2023	367	0.0%	17,620	9/30/2023
2023 Q2	7/27/2023	428	0.0%	17,885	6/30/2023
2023 Q1	5/3/2023	337	0.0%	17,885	3/31/2023
2022 Q4	2/14/2023	285	0.0%	17,885	12/31/2022
2022 Q3	10/31/2022	293	0.0%	17,885	9/30/2022
2022 Q2	7/27/2022	252	0.0%	17,885	6/30/2022
2022 Q1	6/10/2022	434	0.0%	17,910	3/31/2022
2021 Q4	1/25/2022	418	0.0%	17,910	12/31/2021
2021 Q3	10/26/2021	297	0.0%	17,910	9/30/2021
2021 Q2	8/6/2021	437	0.0%	17,910	6/30/2021
2021 Q1	4/28/2021	461	0.0%	17,885	3/31/2021
2020 Q4	2/12/2021	985	0.1%	18,429	12/31/2020
2020 Q3	11/5/2020	792	0.1%	19,204	9/30/2020
2020 Q2	8/7/2020	869	0.1%	17,920	6/30/2020
2019 Q4	1/23/2020	943	0.1%	22,042	12/31/2019